Literature DB >> 21177900

Imipenem-resistant Nocardia cyriacigeorgica infection in a child with chronic granulomatous disease.

Andrés Hagerman1, Verónica Rodríguez-Nava, Patrick Boiron, Pierre-Alex Crisinel, Klara M Posfay-Barbe.   

Abstract

Nocardia spp. can lead to local or disseminated infections, especially in immunocompromised patients. Combination therapy of amikacin and imipenem is commonly used to treat severe nocardial infections. We describe a patient with imipenem-resistant Nocardia cyriacigeorgica, which, to our knowledge, has not been previously reported among isolates of this species.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21177900      PMCID： PMC3067755          DOI： 10.1128/JCM.02073-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  Use of PCR-restriction enzyme pattern analysis and sequencing database for hsp65 gene-based identification of Nocardia species.

Authors:  Verónica Rodríguez-Nava; Andrée Couble; Gregory Devulder; Jean-Pierre Flandrois; Patrick Boiron; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

2.  Nocardia cyriacigeorgica septicemia.

Authors:  Sameer Elsayed; Angela Kealey; Carla S Coffin; Ron Read; David Megran; Kunyan Zhang
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

3.  Nocardia in solid organ transplant recipients.

Authors:  N M Clark
Journal:  Am J Transplant       Date:  2009-12       Impact factor: 8.086

4.  Nocardia cyriacigeorgici sp. nov..

Authors:  A F Yassin; F A Rainey; U Steiner
Journal:  Int J Syst Evol Microbiol       Date:  2001-07       Impact factor: 2.747

5.  Nocardiosis at the turn of the century.

Authors:  Maricela Valerio Minero; Mercedes Marín; Emilia Cercenado; Pablo Martín Rabadán; Emilio Bouza; Patricia Muñoz
Journal:  Medicine (Baltimore)       Date:  2009-07       Impact factor: 1.889

6.  Organisms designated as Nocardia asteroides drug pattern type VI are members of the species Nocardia cyriacigeorgica.

Authors:  Patricia S Conville; Frank G Witebsky
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

7.  Nocardia infection in chronic granulomatous disease.

Authors:  Susan E Dorman; Shireen V Guide; Patricia S Conville; Ellen S DeCarlo; Harry L Malech; John I Gallin; Frank G Witebsky; Steven M Holland
Journal:  Clin Infect Dis       Date:  2002-07-23       Impact factor: 9.079

8.  Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species.

Authors:  Chih-Cheng Lai; Che-Kim Tan; Sheng Hsiang Lin; Chun-Hsing Liao; Chien-Hong Chou; Hsiao-Leng Hsu; Yu-Tsung Huang; Po-Ren Hsueh
Journal:  J Antimicrob Chemother       Date:  2009-04-27       Impact factor: 5.790

Review 9.  Nocardiosis: updated clinical review and experience at a tertiary center.

Authors:  J Ambrosioni; D Lew; J Garbino
Journal:  Infection       Date:  2010-03-20       Impact factor: 7.455
  9 in total
  3 in total

1.  Chronic Granulomatous Disease Due to Neutrophil Cytosolic Factor (NCF2) Gene Mutations in Three Unrelated Families.

Authors:  Pandiarajan Vignesh; Amit Rawat; Ankur Kumar; Deepti Suri; Anju Gupta; Yu L Lau; Koon W Chan; Surjit Singh
Journal:  J Clin Immunol       Date:  2016-12-29       Impact factor: 8.317

2.  Isolation of Nocardia beijingensis from a pulmonary abscess reveals human immunodeficiency virus infection.

Authors:  Christophe Martinaud; Charles Verdonk; Aurore Bousquet; Christine Macnab; Fabien Vaylet; Charles Soler; Thierry Samson; Jacques Margery
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

3.  Nocardiosis Associated with Primary Immunodeficiencies (Nocar-DIP): an International Retrospective Study and Literature Review.

Authors:  Olivier Lortholary; Steven M Holland; Emmanuel Lafont; Beatriz E Marciano; Nizar Mahlaoui; Bénédicte Neven; Jacinta Bustamante; Veronica Rodriguez-Nava; Amit Rawat; Miren Josebe Unzaga; Alain Fischer; Stéphane Blanche; David Lebeaux
Journal:  J Clin Immunol       Date:  2020-09-12       Impact factor: 8.317
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.